.custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

Dr. Anahita Keyhani is Altasciences' Senior Director of Scientific Operations, Mass Spectrometry and Method Development.

June 2020

» ACCESS FULL NEWSLETTER

Discover how certain key factors can contribute towards a more effective clinical recruitment and retention effort.

Learn about the key considerations and best approaches for your bioanalytical sample analysis.

Scientific Journal

Learn about important guidelines and practices to consider for safety pharmacology studies.

Bioanalytical Corner

Take a look at our latest assay list, download copies of scientific posters, and read a recently published article on the application of a new synthetic supported liquid extraction sorbent.

Webinars

Register for upcoming complimentary webinars and view the latest ones on demand!

Podcasts

Meet our CDMO team.

Industry News

See how we stayed at the forefront of COVID-19.

Press Room

Read about the appointment of our Chief Medical Officer and all our latest news!

Blog

Enjoy our latest posts on hot topics in medical science, such as vaccine development realities for COVID-19 and how microsampling is making a difference in drug development.

Comprehensive Drug Manufacturing Solutions

Altasciences' experienced team provides contract manufacturing and analytical services to the pharmaceutical industry, including formulation development, Phase I through commercial manufacturing, and ICH stability testing.

View Biomarkers

At Altasciences, we focus on building long-lasting relationships by understanding your specific needs and delivering on them. We are both responsive and transparent, and know that trust is an important factor in any relationship. We believe that your success is our success. Let us show you what makes Altasciences, a different kind of CDMO.

.custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

First-In-Human and Proof-of-Concept Trials

Over the past decades, Altasciences has designed and conducted over 200 first-in-human and stand-alone proof-of-concept studies. Our comprehensive, full service, early development offerings and experience help you develop sound strategies and allow you to minimize the time taken to make critical go/no-go decisions by harmonizing our clinical pharmacology facilities, biomarker capabilities, PK/PD analysis expertise, and program knowledge.

Subscribe to